Navigation Links


DelSite in Medical News

Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office

New Patent Expands Geographic Coverage IRVING, Texas, Feb. 11 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that the Eurasian Patent Office has granted patent application No. 200600484, titled "Delivery of Physiological Agen...

Carrington's DelSite Presentation at Rodman & Renshaw Conference to be Webcast Live on November 7th

IRVING, Texas, Nov. 5 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today said the upcoming presentation on DelSite Biotechnologies, Inc., its wholly-owned subsidiary, will be webcast live from the Kennedy I Room at the Acumen BioFin Rodman & Renshaw 9th An...

Carrington Subsidiary DelSite to Present at Investor Conference

IRVING, Texas, Nov. 1 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, N...

Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland

Key Presentation by Dr. Yawei Ni, DelSite's CSO, Will Detail Antigen Sparing and Immunoenhancing Attributes of GelSite(R) Polymer IRVING, Texas, Oct. 3 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) today announced that Dr. Yawei Ni, Chief Scientific Officer...

DelSite Chairman George DeMott Resigns

...nto a vaccine and drug delivery company. delsite Biotechnologies, Inc (DSBI) was established as a w...es to DelSite, Inc. in June of this year. delsite continues to transition itself into a more traditi...antigen. I believe the four platforms developed by delsite are based on state-of-the-art science. Several col...

Nosespray vaccine using aloe vera has exciting potential, researcher says

... Veterinary Medicine & Biomedical Sciences. The project is funded in part by a $6 million grant from the National Institutes of Health awarded to delsite Biotechnologies in conjunction with the Texas A&M teams. DelSite, an Irving-based company, has a facility in College Station. Tizard says the metho...

DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations

... IRVING, Texas, Officials of delsite Biotechnologies, Inc., a wholly-owned subsidiary of Carrington Laboratories, Inc. said the company's novel powder-based vaccine delivery technology m...
DelSite in Medical Technology

Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine

- Reaching Critical Development Milestone - Novel, Nasal Powder Vaccine Delivery Technology IRVING, Texas, Aug. 15 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Nasdaq: CARN ) today announced its subsidiary DelSite Biotechnologies, Inc. has initiated the an...
DelSite in Biological Technology

Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration

- Human Trials to Begin Later This Year - Only Nasal Powder Bird Flu Vaccine Under Development - Patient-Friendly (No Needles); No Preservatives - Stable at Room Temperature For 3 Years; No Cold Chain Distribution Required IRVIN...

Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines

Application Would Expand Versatility of DelSite cGMP Polymer IRVING, Texas, Sept. 19 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) today announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., entered into a technology evaluation rights license...

DelSite Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite(R) Polymer

... today announced that its wholly-owned subsidiary, delsite Biotechnologies, Inc., entered into a non-exclusiv... is to evaluate DelSite's parenteral technologies. delsite has agreed to provide GelSite polymer and technica..., president and CEO of Carrington Laboratories and delsite Biotechnologies, commented, "DelSite's technologie...

Carrington Reports 2007 Financial Results

... 2007. Excluding net funding of $2.8 million for delsite Biotechnologies, Inc., the Company's wholly-owned ... 2007 was $7.0 million. 2006's net loss, including delsite net costs of $3.1 million, was $7.6 million, or ($... being developed by DelSite. As previously stated, delsite is currently engaged in the cGMP manufacture of th...

Carrington and Universal Harvest Sign Supply Agreement

...and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its proprietary GelSite(R) polymer technology designed to provide controlled release of peptide and protein-b...

Carrington Settles Lawsuit, Sets Sights On Future

...glad to put this lawsuit behind us without significant financial impact." delsite Biotechnologies, Inc., is Carrington's wholly owned subsidiary that is deve...ompanies. Manufacturing operations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its proprietary GelSite(R) technol...

Carrington Retains Milkie/Ferguson to Explore Financial Alternatives

...and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its proprietary GelSite(R) polymer technology designed to provide controlled release of peptide and protein-b...

GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies

...Board: CARN) today announced that its wholly owned delsite Biotechnologies, Inc. subsidiary has successfully ...to normal FDA regulatory procedures. Separately, delsite successfully completed its second pre-IND meeting ...out DelSite Carrington's wholly owned subsidiary delsite Biotechnologies, Inc. is developing its proprietar...

DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program

... An experimental drug delivery technology from the delsite Biotechnologies subsidiary of Carrington Laborator...FC). The new vaccine technology from Texas-based delsite is the first of its class to eliminate the need fo...perations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its propr...

Carrington Reports Third Quarter 2007 Results

...uble Digit Quarter-to-Quarter Revenue Gain - delsite Continues Toward Phase I Vaccine Clinical Trial ...hare. Pro forma loss for the quarter, exclusive of delsite net funding, was $1.7 million compared to a $1.1 m...perations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its propr...
Other TagsthermthermthermthermthermDecaDecaDecaDeca
(Date:11/26/2009)...,, NEWYORK,Nov.27/PRNewswire/--Withcoldandflu...practicestocontrolthespreadofinfectionsandavoidill...lveshealthy,buttoavoidtransmittingillnessifwe,resi...on-control),nursingdirectorforinfectioncontrolando...nManhattan. ,, HospitalforSpecialSurgeryhasoneo...
(Date:11/26/2009)... In the next 25 years, the number of Americans li...from 23.7 million in 2009 to 44.1 million in 2034....lmost triple, rising from $113 billion to $336 bil...besity, researchers based at the University of Chi...e . , The number of those with diabetes covered ...
(Date:11/26/2009)...Luggage that,s too big or too heavy can lead to st...althDay News) -- There may be nothing wrong with s...t not want to do the same thing with your suitcase...000 people were treated in 2008 in U.S. hospital e...r medical facilities for luggage-related injuries,...
(Date:11/26/2009)... No more letters from the...r,personalized text messages from Santa , ...ffort to increase operational efficiencies at the ...g to help keep children all over the globe informe...,Elves in Santa’s research department have i...
(Date:11/26/2009)... Research Triangle Dental...ntral North Carolina, today announced the expansio...ied LUMINEER Dentist, Dr. Doug Macmillan. , ...ch Triangle Dental is pleased to announce that Dr....t, recently completed an additional advanced train...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
(Date:11/25/2009)... September 11, firefighters, police officers and a...in the World Trade Center complex. They battled to...ched for survivors, tackled fires and evacuated as...ned an estimated 17,000 people. And making their j...ions: frightened workers and their relatives jamme...
(Date:11/25/2009)...o Kent State University assistant professors recen...ndation (NSF) to continue research beneficial to u...al $890,000. , Christopher Blackwood, assistant ..., was awarded grants to support two separate resea...bling Litter Decomposer Communities and Functions ...
(Date:11/24/2009)...cket science is opening new doors to understanding...t the hearing of a marine mammal or if they hear ...ized X-ray scanners that NASA uses to detect flaws...s is now allowing scientists to peek inside the gi...led three-dimensional replicas of a whale,s hearin...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 1Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 3Gambling Addiction Expert Says Treatment Tops Prohibition 57554 1Gambling Addiction Expert Says Treatment Tops Prohibition 57554 2Hard To Treat Diseases 28HTDS 29 28H1N1 29 Vaccine Update 57550 1Hard To Treat Diseases 28HTDS 29 28H1N1 29 Vaccine Update 57550 2Hard To Treat Diseases 28HTDS 29 28H1N1 29 Vaccine Update 57550 3
Other Contentslichensligamentsligamentsligamentsligamentsformformformformformformformformformformligaseligaseligasereactionsreactionsreactionsreactionsreactionsreactionsreactionsreactionsreactionsligationligationligationligationligationligationlimblimblimblimblimblimblimblimblineagelineagelineagelineage